Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Acquisitions (2018)

Historic Acquisitions for Sunshine Biopharma (SBFMW) over the last 1 years, with Q4 2018 value amounting to $9884.0.

  • Sunshine Biopharma's Acquisitions changed N/A to $9884.0 in Q4 2018 from the same period last year, while for Sep 2019 it was $9884.0, marking a year-over-year increase of 30000.0%. This contributed to the annual value of $14.3 million for FY2022, which is N/A changed from last year.
  • Per Sunshine Biopharma's latest filing, its Acquisitions stood at $9884.0 for Q4 2018.
  • Sunshine Biopharma's Acquisitions' 5-year high stood at $80289.0 during Q1 2018, with a 5-year trough of -$85231.0 in Q3 2018.